Byetta which is used to treat Type 2 diabetes, has side effects that could increase the risk of serious and potentially life threatening pancreatitis.
Reports have found an association between Byetta and pancreatitis. Amylin Pharmaceuticals and Eli Lilly & Co., the manufacturers of the defective drug have failed to adequately warn about the risk of the serious and potentially fatal injury.
Byetta lawsuits are being investigated for users diagnosed with:
* Acute Pancreatitis
* Hemorrhagic Pancreatitis
* Necrotizing Pancreatitis
Potential cases are being evaluated throughout the United States.